000627.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 03:04):

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses...

Stats
Today's Volume	23.50M
Average Volume	33.74M
Market Cap	11.12B
EPS	CNY-0.0515 ( 2023-06-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-76.33
ATR14	CNY0.00900 (0.39%)

Volume Correlation

Long: -0.03 (neutral)

Short: 0.00 (neutral)

Signal:(49.006) Neutral

Hubei Biocause Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hubei Biocause Correlation - Currency/Commodity

-0.21
( neutral )

-0.03
( neutral )

0.00
( neutral )

0.25
( neutral )

Hubei Biocause Financials

Annual	2022
Revenue:	CNY49.62B
Gross Profit:	CNY41.16B (82.95 %)
EPS:	CNY0.100

Q3	2023
Revenue:	CNY7.76B
Gross Profit:	CNY6.08B (78.41 %)
EPS:	CNY-0.00520

Q2	2023
Revenue:	CNY11.50B
Gross Profit:	CNY9.18B (79.82 %)
EPS:	CNY-0.0471

Q1	2023
Revenue:	CNY21.93B
Gross Profit:	CNY18.76B (85.55 %)
EPS:	CNY0.0172

Financial Reports:

No articles found.

Hubei Biocause

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.